333 related articles for article (PubMed ID: 16076811)
1. Standards for pharmaceutical advertising in Canada.
Chepesiuk R
CMAJ; 2005 Aug; 173(3):238; author reply 238. PubMed ID: 16076811
[No Abstract] [Full Text] [Related]
2. Editorial policy: industry funding and editorial independence.
MacDonald N; Downie J
CMAJ; 2006 Jun; 174(13):1817, 1819. PubMed ID: 16785448
[No Abstract] [Full Text] [Related]
3. Advertising the new hypnotics.
Finucane TE
J Am Geriatr Soc; 2006 Jan; 54(1):170; author reply 170-2. PubMed ID: 16420219
[No Abstract] [Full Text] [Related]
4. Journals lack explicit policies for separating eds from ads.
Giles J
Nature; 2005 Mar; 434(7033):549. PubMed ID: 15800585
[No Abstract] [Full Text] [Related]
5. [Why this arrogance, Josef Milerad?].
Olin GA
Lakartidningen; 2003 Jan; 100(4):254-5. PubMed ID: 12580016
[No Abstract] [Full Text] [Related]
6. [Five direct questions to Josef Milerad concerning credibility].
Holmgren PG
Lakartidningen; 2003 Jan; 100(5):346, 349. PubMed ID: 12607383
[No Abstract] [Full Text] [Related]
7. [Shoot the messenger!--or the art of changing the subject of conversation].
Zackrisson B
Lakartidningen; 2003 Jan; 100(4):252-3. PubMed ID: 12580015
[No Abstract] [Full Text] [Related]
8. Advertising by pharmaceutical companies in eBMJ. The issue should be debated properly.
McKechnie S
BMJ; 1999 Feb; 318(7183):598-9. PubMed ID: 10037648
[No Abstract] [Full Text] [Related]
9. Pharmaceutical ads in journals.
Lexchin J
Ann Intern Med; 1992 Oct; 117(7):617. PubMed ID: 1524340
[No Abstract] [Full Text] [Related]
10. Little fish are less likely to take the bait.
Marcovitch H
PLoS Med; 2005 Jul; 2(7):e221. PubMed ID: 16033315
[No Abstract] [Full Text] [Related]
11. Focus on the funding and production of evidence rather than its publication.
Sheldon T
PLoS Med; 2005 Jul; 2(7):e222. PubMed ID: 16033316
[No Abstract] [Full Text] [Related]
12. PLoS Medicine and the pharmaceutical industry.
PLoS Medicine Editors
PLoS Med; 2006 Jul; 3(7):e329. PubMed ID: 17149970
[TBL] [Abstract][Full Text] [Related]
13. Ethics in pharmaceutical advertising.
Lober CW
Dermatol Clin; 1993 Apr; 11(2):285-8. PubMed ID: 8477540
[TBL] [Abstract][Full Text] [Related]
14. The PMAC code of marketing practices: time for improvement? Pharmaceutical Manufacturers Association of Canada.
Desjardins JG
CMAJ; 1997 Feb; 156(3):363-4. PubMed ID: 9033417
[TBL] [Abstract][Full Text] [Related]
15. [The journals must honestly tell who is doing the job].
Bergström R
Lakartidningen; 2008 May 7-13; 105(19):1406-7. PubMed ID: 18574981
[No Abstract] [Full Text] [Related]
16. Advertising in dermatology journals: journals' and journal editors' policies, practices, and attitudes.
Bartus CL; Katz KA
J Am Acad Dermatol; 2006 Jul; 55(1):116-22. PubMed ID: 16781302
[TBL] [Abstract][Full Text] [Related]
17. Drug advertisements in Indian medical journals.
Lal A; Sharma ML
Indian J Physiol Pharmacol; 1992 Apr; 36(2):139-40. PubMed ID: 1506082
[No Abstract] [Full Text] [Related]
18. [Release of research results to the public].
Rosenberg J
Ugeskr Laeger; 2009 Nov; 171(47):3419. PubMed ID: 19925724
[No Abstract] [Full Text] [Related]
19. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal.
Lexchin J; Holbrook A
CMAJ; 1994 Jul; 151(1):47-54. PubMed ID: 8004560
[TBL] [Abstract][Full Text] [Related]
20. If it's too good to be true, it probably is.
Kennedy MS
Am J Nurs; 2009 Dec; 109(12):7. PubMed ID: 19935148
[No Abstract] [Full Text] [Related]
[Next] [New Search]
